322 related articles for article (PubMed ID: 15661534)
1. Hsp90 and Cdc37 -- a chaperone cancer conspiracy.
Pearl LH
Curr Opin Genet Dev; 2005 Feb; 15(1):55-61. PubMed ID: 15661534
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells.
Gray PJ; Stevenson MA; Calderwood SK
Cancer Res; 2007 Dec; 67(24):11942-50. PubMed ID: 18089825
[TBL] [Abstract][Full Text] [Related]
3. Cdc37 maintains cellular viability in Schizosaccharomyces pombe independently of interactions with heat-shock protein 90.
Turnbull EL; Martin IV; Fantes PA
FEBS J; 2005 Aug; 272(16):4129-40. PubMed ID: 16098195
[TBL] [Abstract][Full Text] [Related]
4. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
[TBL] [Abstract][Full Text] [Related]
5. Supervision of multiple signaling protein kinases by the CK2-Cdc37 couple, a possible novel cancer therapeutic target.
Miyata Y; Nishida E
Ann N Y Acad Sci; 2004 Dec; 1030():150-7. PubMed ID: 15659792
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
[TBL] [Abstract][Full Text] [Related]
7. The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically.
Abbas-Terki T; Briand PA; Donzé O; Picard D
Biol Chem; 2002 Sep; 383(9):1335-42. PubMed ID: 12437126
[TBL] [Abstract][Full Text] [Related]
8. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
Roiniotis J; Masendycz P; Ho S; Scholz GM
Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
[TBL] [Abstract][Full Text] [Related]
9. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
[TBL] [Abstract][Full Text] [Related]
10. Cdk2: a genuine protein kinase client of Hsp90 and Cdc37.
Prince T; Sun L; Matts RL
Biochemistry; 2005 Nov; 44(46):15287-95. PubMed ID: 16285732
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone.
Workman P
Cancer Lett; 2004 Apr; 206(2):149-57. PubMed ID: 15013520
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of the cell division cycle 37 homolog inhibits endothelial nitric oxide synthase activity.
Harris MB; Bartoli M; Sood SG; Matts RL; Venema RC
Circ Res; 2006 Feb; 98(3):335-41. PubMed ID: 16410463
[TBL] [Abstract][Full Text] [Related]
13. A client-binding site of Cdc37.
Terasawa K; Minami Y
FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
[TBL] [Abstract][Full Text] [Related]
14. Exposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37.
Prince T; Matts RL
Biochem Biophys Res Commun; 2005 Dec; 338(3):1447-54. PubMed ID: 16269130
[TBL] [Abstract][Full Text] [Related]
15. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
Stetz G; Verkhivker GM
J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
[TBL] [Abstract][Full Text] [Related]
16. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
[TBL] [Abstract][Full Text] [Related]
17. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
Smith JR; Clarke PA; de Billy E; Workman P
Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700
[TBL] [Abstract][Full Text] [Related]
18. Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia.
Stepanova L; Yang G; DeMayo F; Wheeler TM; Finegold M; Thompson TC; Harper JW
Oncogene; 2000 Apr; 19(18):2186-93. PubMed ID: 10822368
[TBL] [Abstract][Full Text] [Related]
19. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
Ota A; Zhang J; Ping P; Han J; Wang Y
Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
[TBL] [Abstract][Full Text] [Related]
20. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
McDowell CL; Bryan Sutton R; Obermann WM
Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
